These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 28566118)
1. NBOMe hallucinogenic drug exposures reported to the Danish Poison Information Centre. Madsen GR; Petersen TS; Dalhoff KP Dan Med J; 2017 Jun; 64(6):. PubMed ID: 28566118 [TBL] [Abstract][Full Text] [Related]
2. NBOMe and 2C substitute phenylethylamine exposures reported to the National Poison Data System. Srisuma S; Bronstein AC; Hoyte CO Clin Toxicol (Phila); 2015; 53(7):624-8. PubMed ID: 26065360 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of use and acute toxicity associated with the use of NBOMe drugs. Wood DM; Sedefov R; Cunningham A; Dargan PI Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166 [TBL] [Abstract][Full Text] [Related]
5. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015. Heise CW; Brooks DE J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660 [TBL] [Abstract][Full Text] [Related]
6. Retrospective Demonstration of 25I-NBOMe Acute Poisoning Using Hair Analysis. Ameline A; Farrugia A; Raul JS; Kintz P Curr Pharm Biotechnol; 2017; 18(10):786-790. PubMed ID: 29189143 [TBL] [Abstract][Full Text] [Related]
8. Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe. Tang MH; Ching CK; Tsui MS; Chu FK; Mak TW Clin Toxicol (Phila); 2014 Jun; 52(5):561-5. PubMed ID: 24779864 [TBL] [Abstract][Full Text] [Related]
9. Outcomes following calcium channel blocker exposures reported to a poison information center. Christensen MB; Petersen KM; Bøgevig S; Al-Gibouri S; Jimenez-Solem E; Dalhoff KP; Petersen TS; Andersen JT BMC Pharmacol Toxicol; 2018 Nov; 19(1):78. PubMed ID: 30482251 [TBL] [Abstract][Full Text] [Related]
10. Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe. Laskowski LK; Elbakoush F; Calvo J; Exantus-Bernard G; Fong J; Poklis JL; Poklis A; Nelson LS J Med Toxicol; 2015 Jun; 11(2):237-41. PubMed ID: 25387562 [TBL] [Abstract][Full Text] [Related]
11. 25I-NBOMe related death in Australia: a case report. Kueppers VB; Cooke CT Forensic Sci Int; 2015 Apr; 249():e15-8. PubMed ID: 25747271 [TBL] [Abstract][Full Text] [Related]
12. Synthetic cathinone exposures reported to Texas poison centers. Forrester MB Am J Drug Alcohol Abuse; 2012 Nov; 38(6):609-15. PubMed ID: 22541001 [TBL] [Abstract][Full Text] [Related]
13. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper. Poklis JL; Raso SA; Alford KN; Poklis A; Peace MR J Anal Toxicol; 2015 Oct; 39(8):617-23. PubMed ID: 26378135 [TBL] [Abstract][Full Text] [Related]
14. Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature. Suzuki J; Dekker MA; Valenti ES; Arbelo Cruz FA; Correa AM; Poklis JL; Poklis A Psychosomatics; 2015; 56(2):129-39. PubMed ID: 25659919 [TBL] [Abstract][Full Text] [Related]
15. A Danish Survey of Antihistamine Use and Poisoning Patterns. Jensen LL; Rømsing J; Dalhoff K Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):64-70. PubMed ID: 27288889 [TBL] [Abstract][Full Text] [Related]
16. Recreational phenethylamine poisonings reported to a French poison control center. Le Roux G; Bruneau C; Lelièvre B; Bretaudeau Deguigne M; Turcant A; Harry P; Boels D Drug Alcohol Depend; 2015 Sep; 154():46-53. PubMed ID: 26205314 [TBL] [Abstract][Full Text] [Related]
17. A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug. Rose SR; Poklis JL; Poklis A Clin Toxicol (Phila); 2013 Mar; 51(3):174-7. PubMed ID: 23473462 [TBL] [Abstract][Full Text] [Related]
18. Status and trends in poisonings in Denmark 2007-2009. Bøgevig S; Høgberg LC; Dalhoff KP; Mortensen OS Dan Med Bull; 2011 May; 58(5):A4268. PubMed ID: 21535985 [TBL] [Abstract][Full Text] [Related]